PFIZER'S ANTI-SMOKING PILL CHAMPIX APPROVED IN EUROPE

Pfizer Inc said that the European Commission has approved Champix (varenicline), a novel pill for smoking cessation in adults. In addition, because smokers often need considerable support to quit successfully, Champix will be available with a patient support plan which smokers can customize to address their individual behavioral triggers as they try to quit smoking. Medical News Today (http://www.medicalnewstoday.com/medicalnews.php?newsid=53058)